HILLSIDE, N.J., April 25 /PRNewswire-FirstCall/ -- AgroLabs, Inc., a wholly owned subsidiary of Integrated BioPharma, Inc. , announces the beginning of its relationship with Ralphs Grocery Company stores in Southern California. Three of its healthful Naturally juice supplements will be available in 115 of Ralphs' stores starting the first week of May 2006.
Ralphs is a division of The Kroger Co., one of the nation's largest grocery retailers, with fiscal 2005 sales of $60.6 billion.
Kurt E. Cahill, chief operating officer of AgroLabs, stated, "Ralphs will be carrying our Naturally Noni, Naturally Pomegranate and Naturally Thai Mangosteen beverages all in 16 fluid ounce bottles. We are pleased to add the Ralphs Southern California stores to our growing list of retail outlets that are offering our superfruit liquid supplements. This reflects America's continuing thirst for health-oriented products."
E. Gerald Kay, Chief Executive Officer of INB, added, "AgroLabs continues to expand the availability of its liquid, healthful, nutritional products. The addition of Ralphs expands our retail distribution channels which currently include Costco, Wal-Mart, Sam's Clubs and BJ's Wholesale Club stores. Our AgroLabs subsidiary continues to focus on building broad distribution of our product lines and our identity as a leading provider of healthful nutritional products."
AgroLabs, Inc. distributes and markets healthful nutritional products under the following brands: Naturally Aloe, Naturally Noni, Naturally Pomegranate, Naturally Thai Mangosteen and most recently, Acai Extreme Energy. These products are distributed nationwide through major mass market, grocery, drug and vitamin retailers. Additional information on AgroLabs and its products can be obtained from its website at http://www.agrolabs.com or by calling (817) 410-2140.
About Integrated BioPharma Inc. (INB)
Integrated BioPharma is a unique grouping of companies presently serving the varied needs of the health care industry. Through its nutraceutical business, the Company creates, develops, manufactures and markets products worldwide. The Company's biotechnology business uses its patented plant-based technology to produce vaccines and therapeutic antibodies. Its pharmaceutical business operates a cGMP facility for the production and sale of Paclitaxel and related drugs and provides technical services through its contract research organization. Further information is available at http://www.iBioPharma.com.
Statements included in this release related to Integrated BioPharma, Inc. may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand, and the company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential risk factors that could affect the company's financial results can be found in the company's Reports filed with the Securities and Exchange Commission.
Integrated BioPharma, Inc.CONTACT: Dina Masi, CFO of Integrated BioPharma, Inc., 1-888-319-6962,d.masi@ibiopharma.com
